nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—SLCO1B1—Mycophenolate mofetil—psoriasis	0.112	0.344	CbGbCtD
Acetylcysteine—SLCO1B1—Cyclosporine—psoriasis	0.0845	0.261	CbGbCtD
Acetylcysteine—SLC22A6—Cyclosporine—psoriasis	0.0543	0.168	CbGbCtD
Acetylcysteine—SLCO1B1—Methotrexate—psoriasis	0.0447	0.138	CbGbCtD
Acetylcysteine—SLC22A6—Methotrexate—psoriasis	0.0288	0.0888	CbGbCtD
Acetylcysteine—SLC7A11—Dexamethasone—Clobetasol propionate—psoriasis	0.0011	0.0968	CbGdCrCtD
Acetylcysteine—SLC7A11—Betamethasone—Clobetasol propionate—psoriasis	0.0011	0.0968	CbGdCrCtD
Acetylcysteine—SLC7A11—Betamethasone—Fluocinonide—psoriasis	0.000881	0.0776	CbGdCrCtD
Acetylcysteine—SLC7A11—Betamethasone—Beclomethasone—psoriasis	0.000881	0.0776	CbGdCrCtD
Acetylcysteine—SLC7A11—Dexamethasone—Fluocinonide—psoriasis	0.000881	0.0776	CbGdCrCtD
Acetylcysteine—SLC7A11—Dexamethasone—Beclomethasone—psoriasis	0.000881	0.0776	CbGdCrCtD
Acetylcysteine—SLC7A11—Betamethasone—Fluocinolone Acetonide—psoriasis	0.000856	0.0754	CbGdCrCtD
Acetylcysteine—SLC7A11—Dexamethasone—Fluocinolone Acetonide—psoriasis	0.000856	0.0754	CbGdCrCtD
Acetylcysteine—Cough—Mycophenolic acid—psoriasis	0.000605	0.00173	CcSEcCtD
Acetylcysteine—Dyspnoea—Hydroxyurea—psoriasis	0.000602	0.00173	CcSEcCtD
Acetylcysteine—Somnolence—Hydroxyurea—psoriasis	0.0006	0.00172	CcSEcCtD
Acetylcysteine—Flushing—Cyclosporine—psoriasis	0.000598	0.00171	CcSEcCtD
Acetylcysteine—Dyspepsia—Hydroxyurea—psoriasis	0.000594	0.0017	CcSEcCtD
Acetylcysteine—Face oedema—Prednisone—psoriasis	0.000594	0.0017	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	0.000586	0.00168	CcSEcCtD
Acetylcysteine—Angiopathy—Cyclosporine—psoriasis	0.000584	0.00167	CcSEcCtD
Acetylcysteine—Cardiac disorder—Mycophenolate mofetil—psoriasis	0.000583	0.00167	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000583	0.00167	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Cyclosporine—psoriasis	0.00058	0.00166	CcSEcCtD
Acetylcysteine—Nausea—Calcitriol—psoriasis	0.000574	0.00165	CcSEcCtD
Acetylcysteine—Angiopathy—Mycophenolate mofetil—psoriasis	0.00057	0.00163	CcSEcCtD
Acetylcysteine—Dizziness—Acitretin—psoriasis	0.000569	0.00163	CcSEcCtD
Acetylcysteine—Dizziness—Fluocinolone Acetonide—psoriasis	0.000567	0.00163	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Mycophenolate mofetil—psoriasis	0.000566	0.00162	CcSEcCtD
Acetylcysteine—Oedema—Mycophenolic acid—psoriasis	0.000565	0.00162	CcSEcCtD
Acetylcysteine—Shock—Mycophenolic acid—psoriasis	0.000556	0.00159	CcSEcCtD
Acetylcysteine—Tachycardia—Mycophenolic acid—psoriasis	0.000552	0.00158	CcSEcCtD
Acetylcysteine—Skin disorder—Mycophenolic acid—psoriasis	0.000549	0.00157	CcSEcCtD
Acetylcysteine—Vomiting—Acitretin—psoriasis	0.000547	0.00157	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Mycophenolic acid—psoriasis	0.000547	0.00157	CcSEcCtD
Acetylcysteine—Vomiting—Fluocinolone Acetonide—psoriasis	0.000545	0.00156	CcSEcCtD
Acetylcysteine—Rash—Acitretin—psoriasis	0.000542	0.00155	CcSEcCtD
Acetylcysteine—Dermatitis—Acitretin—psoriasis	0.000542	0.00155	CcSEcCtD
Acetylcysteine—Rash—Fluocinolone Acetonide—psoriasis	0.000541	0.00155	CcSEcCtD
Acetylcysteine—Dermatitis—Fluocinolone Acetonide—psoriasis	0.00054	0.00155	CcSEcCtD
Acetylcysteine—Pharyngitis—Triamcinolone—psoriasis	0.000535	0.00153	CcSEcCtD
Acetylcysteine—Body temperature increased—Hydroxyurea—psoriasis	0.000534	0.00153	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Methotrexate—psoriasis	0.000531	0.00152	CcSEcCtD
Acetylcysteine—Hypotension—Mycophenolic acid—psoriasis	0.000528	0.00151	CcSEcCtD
Acetylcysteine—Immune system disorder—Hydrocortisone—psoriasis	0.000517	0.00148	CcSEcCtD
Acetylcysteine—Angioedema—Cyclosporine—psoriasis	0.000512	0.00147	CcSEcCtD
Acetylcysteine—Nausea—Acitretin—psoriasis	0.000511	0.00146	CcSEcCtD
Acetylcysteine—Erythema—Prednisolone—psoriasis	0.00051	0.00146	CcSEcCtD
Acetylcysteine—Nausea—Fluocinolone Acetonide—psoriasis	0.000509	0.00146	CcSEcCtD
Acetylcysteine—Dyspnoea—Mycophenolic acid—psoriasis	0.000504	0.00145	CcSEcCtD
Acetylcysteine—Somnolence—Mycophenolic acid—psoriasis	0.000503	0.00144	CcSEcCtD
Acetylcysteine—Angioedema—Mycophenolate mofetil—psoriasis	0.0005	0.00143	CcSEcCtD
Acetylcysteine—Erythema—Hydrocortisone—psoriasis	0.000498	0.00143	CcSEcCtD
Acetylcysteine—Dyspepsia—Mycophenolic acid—psoriasis	0.000498	0.00143	CcSEcCtD
Acetylcysteine—Hypersensitivity—Hydroxyurea—psoriasis	0.000497	0.00143	CcSEcCtD
Acetylcysteine—Syncope—Mycophenolate mofetil—psoriasis	0.00049	0.00141	CcSEcCtD
Acetylcysteine—Cough—Cyclosporine—psoriasis	0.000489	0.0014	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000488	0.0014	CcSEcCtD
Acetylcysteine—Loss of consciousness—Mycophenolate mofetil—psoriasis	0.000481	0.00138	CcSEcCtD
Acetylcysteine—Cough—Mycophenolate mofetil—psoriasis	0.000477	0.00137	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.000474	0.00136	CcSEcCtD
Acetylcysteine—Erythema—Triamcinolone—psoriasis	0.000469	0.00134	CcSEcCtD
Acetylcysteine—Angioedema—Prednisolone—psoriasis	0.000466	0.00134	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000462	0.00133	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Cyclosporine—psoriasis	0.000457	0.00131	CcSEcCtD
Acetylcysteine—Oedema—Cyclosporine—psoriasis	0.000457	0.00131	CcSEcCtD
Acetylcysteine—Syncope—Prednisolone—psoriasis	0.000457	0.00131	CcSEcCtD
Acetylcysteine—Angioedema—Hydrocortisone—psoriasis	0.000455	0.0013	CcSEcCtD
Acetylcysteine—Loss of consciousness—Prednisolone—psoriasis	0.000448	0.00129	CcSEcCtD
Acetylcysteine—Body temperature increased—Mycophenolic acid—psoriasis	0.000447	0.00128	CcSEcCtD
Acetylcysteine—Syncope—Hydrocortisone—psoriasis	0.000447	0.00128	CcSEcCtD
Acetylcysteine—Dizziness—Hydroxyurea—psoriasis	0.000446	0.00128	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.000446	0.00128	CcSEcCtD
Acetylcysteine—Oedema—Mycophenolate mofetil—psoriasis	0.000446	0.00128	CcSEcCtD
Acetylcysteine—Asthma—Methotrexate—psoriasis	0.000445	0.00127	CcSEcCtD
Acetylcysteine—Skin disorder—Cyclosporine—psoriasis	0.000444	0.00127	CcSEcCtD
Acetylcysteine—Angiopathy—Dexamethasone—psoriasis	0.000444	0.00127	CcSEcCtD
Acetylcysteine—Angiopathy—Betamethasone—psoriasis	0.000444	0.00127	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Cyclosporine—psoriasis	0.000442	0.00127	CcSEcCtD
Acetylcysteine—Shock—Mycophenolate mofetil—psoriasis	0.000439	0.00126	CcSEcCtD
Acetylcysteine—Loss of consciousness—Hydrocortisone—psoriasis	0.000438	0.00126	CcSEcCtD
Acetylcysteine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000436	0.00125	CcSEcCtD
Acetylcysteine—Skin disorder—Mycophenolate mofetil—psoriasis	0.000433	0.00124	CcSEcCtD
Acetylcysteine—SLC7A11—Betamethasone—Hydrocortisone—psoriasis	0.000432	0.0381	CbGdCrCtD
Acetylcysteine—SLC7A11—Dexamethasone—Hydrocortisone—psoriasis	0.000432	0.0381	CbGdCrCtD
Acetylcysteine—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000431	0.00124	CcSEcCtD
Acetylcysteine—Vomiting—Hydroxyurea—psoriasis	0.000429	0.00123	CcSEcCtD
Acetylcysteine—Angioedema—Triamcinolone—psoriasis	0.000429	0.00123	CcSEcCtD
Acetylcysteine—Rash—Hydroxyurea—psoriasis	0.000426	0.00122	CcSEcCtD
Acetylcysteine—Erythema—Betamethasone—psoriasis	0.000426	0.00122	CcSEcCtD
Acetylcysteine—Erythema—Dexamethasone—psoriasis	0.000426	0.00122	CcSEcCtD
Acetylcysteine—Dermatitis—Hydroxyurea—psoriasis	0.000425	0.00122	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000421	0.00121	CcSEcCtD
Acetylcysteine—Syncope—Triamcinolone—psoriasis	0.000421	0.00121	CcSEcCtD
Acetylcysteine—Hypotension—Mycophenolate mofetil—psoriasis	0.000417	0.0012	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Prednisolone—psoriasis	0.000416	0.00119	CcSEcCtD
Acetylcysteine—Oedema—Prednisolone—psoriasis	0.000416	0.00119	CcSEcCtD
Acetylcysteine—Loss of consciousness—Triamcinolone—psoriasis	0.000412	0.00118	CcSEcCtD
Acetylcysteine—Shock—Prednisolone—psoriasis	0.00041	0.00117	CcSEcCtD
Acetylcysteine—Cough—Triamcinolone—psoriasis	0.000409	0.00117	CcSEcCtD
Acetylcysteine—Dyspnoea—Cyclosporine—psoriasis	0.000408	0.00117	CcSEcCtD
Acetylcysteine—Somnolence—Cyclosporine—psoriasis	0.000407	0.00117	CcSEcCtD
Acetylcysteine—Oedema—Hydrocortisone—psoriasis	0.000407	0.00117	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Hydrocortisone—psoriasis	0.000407	0.00117	CcSEcCtD
Acetylcysteine—Tachycardia—Prednisolone—psoriasis	0.000406	0.00116	CcSEcCtD
Acetylcysteine—Dyspepsia—Cyclosporine—psoriasis	0.000403	0.00115	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Prednisolone—psoriasis	0.000402	0.00115	CcSEcCtD
Acetylcysteine—SLC7A11—Dexamethasone—Betamethasone—psoriasis	0.000402	0.0353	CbGdCrCtD
Acetylcysteine—SLC7A11—Betamethasone—Dexamethasone—psoriasis	0.000402	0.0353	CbGdCrCtD
Acetylcysteine—Nausea—Hydroxyurea—psoriasis	0.000401	0.00115	CcSEcCtD
Acetylcysteine—Pruritus—Mycophenolic acid—psoriasis	0.0004	0.00115	CcSEcCtD
Acetylcysteine—Shock—Hydrocortisone—psoriasis	0.0004	0.00115	CcSEcCtD
Acetylcysteine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000398	0.00114	CcSEcCtD
Acetylcysteine—Tachycardia—Hydrocortisone—psoriasis	0.000397	0.00114	CcSEcCtD
Acetylcysteine—Somnolence—Mycophenolate mofetil—psoriasis	0.000397	0.00114	CcSEcCtD
Acetylcysteine—Drowsiness—Methotrexate—psoriasis	0.000396	0.00114	CcSEcCtD
Acetylcysteine—Flushing—Prednisone—psoriasis	0.000395	0.00113	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000395	0.00113	CcSEcCtD
Acetylcysteine—Skin disorder—Hydrocortisone—psoriasis	0.000395	0.00113	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Hydrocortisone—psoriasis	0.000393	0.00113	CcSEcCtD
Acetylcysteine—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000393	0.00113	CcSEcCtD
Acetylcysteine—SLC7A11—Dexamethasone—Triamcinolone—psoriasis	0.000392	0.0345	CbGdCrCtD
Acetylcysteine—SLC7A11—Betamethasone—Triamcinolone—psoriasis	0.000392	0.0345	CbGdCrCtD
Acetylcysteine—Angioedema—Betamethasone—psoriasis	0.000389	0.00111	CcSEcCtD
Acetylcysteine—Angioedema—Dexamethasone—psoriasis	0.000389	0.00111	CcSEcCtD
Acetylcysteine—Stomatitis—Methotrexate—psoriasis	0.000386	0.00111	CcSEcCtD
Acetylcysteine—Angiopathy—Prednisone—psoriasis	0.000386	0.00111	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000385	0.0011	CcSEcCtD
Acetylcysteine—Immune system disorder—Prednisone—psoriasis	0.000385	0.0011	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Triamcinolone—psoriasis	0.000383	0.0011	CcSEcCtD
Acetylcysteine—Oedema—Triamcinolone—psoriasis	0.000383	0.0011	CcSEcCtD
Acetylcysteine—Syncope—Dexamethasone—psoriasis	0.000382	0.00109	CcSEcCtD
Acetylcysteine—Syncope—Betamethasone—psoriasis	0.000382	0.00109	CcSEcCtD
Acetylcysteine—Sweating—Methotrexate—psoriasis	0.00038	0.00109	CcSEcCtD
Acetylcysteine—Hypotension—Hydrocortisone—psoriasis	0.00038	0.00109	CcSEcCtD
Acetylcysteine—Shock—Triamcinolone—psoriasis	0.000377	0.00108	CcSEcCtD
Acetylcysteine—Loss of consciousness—Betamethasone—psoriasis	0.000374	0.00107	CcSEcCtD
Acetylcysteine—Loss of consciousness—Dexamethasone—psoriasis	0.000374	0.00107	CcSEcCtD
Acetylcysteine—Dizziness—Mycophenolic acid—psoriasis	0.000374	0.00107	CcSEcCtD
Acetylcysteine—Tachycardia—Triamcinolone—psoriasis	0.000374	0.00107	CcSEcCtD
Acetylcysteine—SLC7A11—Dexamethasone—Prednisone—psoriasis	0.000372	0.0328	CbGdCrCtD
Acetylcysteine—SLC7A11—Betamethasone—Prednisone—psoriasis	0.000372	0.0328	CbGdCrCtD
Acetylcysteine—Erythema—Prednisone—psoriasis	0.000371	0.00106	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Triamcinolone—psoriasis	0.00037	0.00106	CcSEcCtD
Acetylcysteine—SLC7A11—Betamethasone—Prednisolone—psoriasis	0.000363	0.032	CbGdCrCtD
Acetylcysteine—SLC7A11—Dexamethasone—Prednisolone—psoriasis	0.000363	0.032	CbGdCrCtD
Acetylcysteine—Urticaria—Cyclosporine—psoriasis	0.000363	0.00104	CcSEcCtD
Acetylcysteine—Body temperature increased—Cyclosporine—psoriasis	0.000362	0.00104	CcSEcCtD
Acetylcysteine—Vomiting—Mycophenolic acid—psoriasis	0.00036	0.00103	CcSEcCtD
Acetylcysteine—Dyspepsia—Hydrocortisone—psoriasis	0.000358	0.00103	CcSEcCtD
Acetylcysteine—Rash—Mycophenolic acid—psoriasis	0.000357	0.00102	CcSEcCtD
Acetylcysteine—Dermatitis—Mycophenolic acid—psoriasis	0.000356	0.00102	CcSEcCtD
Acetylcysteine—Urticaria—Mycophenolate mofetil—psoriasis	0.000355	0.00102	CcSEcCtD
Acetylcysteine—Pharyngitis—Methotrexate—psoriasis	0.000353	0.00101	CcSEcCtD
Acetylcysteine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000353	0.00101	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000351	0.00101	CcSEcCtD
Acetylcysteine—Oedema—Dexamethasone—psoriasis	0.000347	0.000996	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Dexamethasone—psoriasis	0.000347	0.000996	CcSEcCtD
Acetylcysteine—Oedema—Betamethasone—psoriasis	0.000347	0.000996	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Betamethasone—psoriasis	0.000347	0.000996	CcSEcCtD
Acetylcysteine—Shock—Betamethasone—psoriasis	0.000342	0.00098	CcSEcCtD
Acetylcysteine—Shock—Dexamethasone—psoriasis	0.000342	0.00098	CcSEcCtD
Acetylcysteine—Dyspnoea—Triamcinolone—psoriasis	0.000341	0.000978	CcSEcCtD
Acetylcysteine—Tachycardia—Dexamethasone—psoriasis	0.000339	0.000972	CcSEcCtD
Acetylcysteine—Tachycardia—Betamethasone—psoriasis	0.000339	0.000972	CcSEcCtD
Acetylcysteine—Angioedema—Prednisone—psoriasis	0.000339	0.000971	CcSEcCtD
Acetylcysteine—Hypersensitivity—Cyclosporine—psoriasis	0.000337	0.000966	CcSEcCtD
Acetylcysteine—Dyspepsia—Triamcinolone—psoriasis	0.000337	0.000966	CcSEcCtD
Acetylcysteine—Nausea—Mycophenolic acid—psoriasis	0.000336	0.000963	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Dexamethasone—psoriasis	0.000336	0.000963	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Betamethasone—psoriasis	0.000336	0.000963	CcSEcCtD
Acetylcysteine—Syncope—Prednisone—psoriasis	0.000332	0.000953	CcSEcCtD
Acetylcysteine—Urticaria—Prednisolone—psoriasis	0.000331	0.000948	CcSEcCtD
Acetylcysteine—Cardiac disorder—Methotrexate—psoriasis	0.00033	0.000947	CcSEcCtD
Acetylcysteine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000329	0.000942	CcSEcCtD
Acetylcysteine—Loss of consciousness—Prednisone—psoriasis	0.000326	0.000934	CcSEcCtD
Acetylcysteine—Hypotension—Betamethasone—psoriasis	0.000325	0.00093	CcSEcCtD
Acetylcysteine—Hypotension—Dexamethasone—psoriasis	0.000325	0.00093	CcSEcCtD
Acetylcysteine—Pruritus—Cyclosporine—psoriasis	0.000324	0.000928	CcSEcCtD
Acetylcysteine—Urticaria—Hydrocortisone—psoriasis	0.000323	0.000926	CcSEcCtD
Acetylcysteine—Angiopathy—Methotrexate—psoriasis	0.000323	0.000925	CcSEcCtD
Acetylcysteine—Immune system disorder—Methotrexate—psoriasis	0.000321	0.000921	CcSEcCtD
Acetylcysteine—Body temperature increased—Hydrocortisone—psoriasis	0.000321	0.000921	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Methotrexate—psoriasis	0.000321	0.000919	CcSEcCtD
Acetylcysteine—Pruritus—Mycophenolate mofetil—psoriasis	0.000316	0.000905	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000313	0.000898	CcSEcCtD
Acetylcysteine—Erythema—Methotrexate—psoriasis	0.00031	0.000888	CcSEcCtD
Acetylcysteine—Hypersensitivity—Prednisolone—psoriasis	0.000307	0.000879	CcSEcCtD
Acetylcysteine—Dyspepsia—Betamethasone—psoriasis	0.000306	0.000876	CcSEcCtD
Acetylcysteine—Dyspepsia—Dexamethasone—psoriasis	0.000306	0.000876	CcSEcCtD
Acetylcysteine—Urticaria—Triamcinolone—psoriasis	0.000304	0.000872	CcSEcCtD
Acetylcysteine—Body temperature increased—Triamcinolone—psoriasis	0.000303	0.000867	CcSEcCtD
Acetylcysteine—Dizziness—Cyclosporine—psoriasis	0.000303	0.000867	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Prednisone—psoriasis	0.000302	0.000867	CcSEcCtD
Acetylcysteine—Oedema—Prednisone—psoriasis	0.000302	0.000867	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Dexamethasone—psoriasis	0.0003	0.00086	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Betamethasone—psoriasis	0.0003	0.00086	CcSEcCtD
Acetylcysteine—Hypersensitivity—Hydrocortisone—psoriasis	0.0003	0.000859	CcSEcCtD
Acetylcysteine—Shock—Prednisone—psoriasis	0.000298	0.000853	CcSEcCtD
Acetylcysteine—Tachycardia—Prednisone—psoriasis	0.000295	0.000846	CcSEcCtD
Acetylcysteine—Dizziness—Mycophenolate mofetil—psoriasis	0.000295	0.000846	CcSEcCtD
Acetylcysteine—Skin disorder—Prednisone—psoriasis	0.000294	0.000842	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Prednisone—psoriasis	0.000292	0.000838	CcSEcCtD
Acetylcysteine—Vomiting—Cyclosporine—psoriasis	0.000291	0.000834	CcSEcCtD
Acetylcysteine—Rash—Cyclosporine—psoriasis	0.000288	0.000827	CcSEcCtD
Acetylcysteine—Dermatitis—Cyclosporine—psoriasis	0.000288	0.000826	CcSEcCtD
Acetylcysteine—Pruritus—Hydrocortisone—psoriasis	0.000288	0.000825	CcSEcCtD
Acetylcysteine—Vomiting—Mycophenolate mofetil—psoriasis	0.000284	0.000813	CcSEcCtD
Acetylcysteine—Hypersensitivity—Triamcinolone—psoriasis	0.000282	0.000808	CcSEcCtD
Acetylcysteine—Rash—Mycophenolate mofetil—psoriasis	0.000281	0.000807	CcSEcCtD
Acetylcysteine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000281	0.000806	CcSEcCtD
Acetylcysteine—Urticaria—Betamethasone—psoriasis	0.000276	0.000791	CcSEcCtD
Acetylcysteine—Urticaria—Dexamethasone—psoriasis	0.000276	0.000791	CcSEcCtD
Acetylcysteine—Dizziness—Prednisolone—psoriasis	0.000275	0.000789	CcSEcCtD
Acetylcysteine—Body temperature increased—Betamethasone—psoriasis	0.000275	0.000787	CcSEcCtD
Acetylcysteine—Body temperature increased—Dexamethasone—psoriasis	0.000275	0.000787	CcSEcCtD
Acetylcysteine—Nausea—Cyclosporine—psoriasis	0.000272	0.000779	CcSEcCtD
Acetylcysteine—Pruritus—Triamcinolone—psoriasis	0.000271	0.000776	CcSEcCtD
Acetylcysteine—Cough—Methotrexate—psoriasis	0.00027	0.000775	CcSEcCtD
Acetylcysteine—Dizziness—Hydrocortisone—psoriasis	0.000269	0.000771	CcSEcCtD
Acetylcysteine—Dyspepsia—Prednisone—psoriasis	0.000266	0.000763	CcSEcCtD
Acetylcysteine—Nausea—Mycophenolate mofetil—psoriasis	0.000265	0.00076	CcSEcCtD
Acetylcysteine—Rash—Prednisolone—psoriasis	0.000262	0.000752	CcSEcCtD
Acetylcysteine—Dermatitis—Prednisolone—psoriasis	0.000262	0.000752	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000262	0.000751	CcSEcCtD
Acetylcysteine—Vomiting—Hydrocortisone—psoriasis	0.000258	0.000741	CcSEcCtD
Acetylcysteine—Rash—Hydrocortisone—psoriasis	0.000256	0.000735	CcSEcCtD
Acetylcysteine—Dermatitis—Hydrocortisone—psoriasis	0.000256	0.000734	CcSEcCtD
Acetylcysteine—Dizziness—Triamcinolone—psoriasis	0.000253	0.000726	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Methotrexate—psoriasis	0.000253	0.000725	CcSEcCtD
Acetylcysteine—Nausea—Prednisolone—psoriasis	0.000247	0.000709	CcSEcCtD
Acetylcysteine—Pruritus—Betamethasone—psoriasis	0.000246	0.000704	CcSEcCtD
Acetylcysteine—Pruritus—Dexamethasone—psoriasis	0.000246	0.000704	CcSEcCtD
Acetylcysteine—Skin disorder—Methotrexate—psoriasis	0.000246	0.000704	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Methotrexate—psoriasis	0.000244	0.000701	CcSEcCtD
Acetylcysteine—Vomiting—Triamcinolone—psoriasis	0.000243	0.000698	CcSEcCtD
Acetylcysteine—Nausea—Hydrocortisone—psoriasis	0.000241	0.000692	CcSEcCtD
Acetylcysteine—Rash—Triamcinolone—psoriasis	0.000241	0.000692	CcSEcCtD
Acetylcysteine—Dermatitis—Triamcinolone—psoriasis	0.000241	0.000691	CcSEcCtD
Acetylcysteine—Urticaria—Prednisone—psoriasis	0.00024	0.000689	CcSEcCtD
Acetylcysteine—Body temperature increased—Prednisone—psoriasis	0.000239	0.000685	CcSEcCtD
Acetylcysteine—Hypotension—Methotrexate—psoriasis	0.000236	0.000677	CcSEcCtD
Acetylcysteine—Dizziness—Dexamethasone—psoriasis	0.00023	0.000658	CcSEcCtD
Acetylcysteine—Dizziness—Betamethasone—psoriasis	0.00023	0.000658	CcSEcCtD
Acetylcysteine—Nausea—Triamcinolone—psoriasis	0.000227	0.000652	CcSEcCtD
Acetylcysteine—Dyspnoea—Methotrexate—psoriasis	0.000225	0.000646	CcSEcCtD
Acetylcysteine—Somnolence—Methotrexate—psoriasis	0.000225	0.000644	CcSEcCtD
Acetylcysteine—Hypersensitivity—Prednisone—psoriasis	0.000223	0.000639	CcSEcCtD
Acetylcysteine—Dyspepsia—Methotrexate—psoriasis	0.000223	0.000638	CcSEcCtD
Acetylcysteine—Vomiting—Dexamethasone—psoriasis	0.000221	0.000633	CcSEcCtD
Acetylcysteine—Vomiting—Betamethasone—psoriasis	0.000221	0.000633	CcSEcCtD
Acetylcysteine—Rash—Dexamethasone—psoriasis	0.000219	0.000628	CcSEcCtD
Acetylcysteine—Rash—Betamethasone—psoriasis	0.000219	0.000628	CcSEcCtD
Acetylcysteine—Dermatitis—Dexamethasone—psoriasis	0.000219	0.000627	CcSEcCtD
Acetylcysteine—Dermatitis—Betamethasone—psoriasis	0.000219	0.000627	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Methotrexate—psoriasis	0.000218	0.000626	CcSEcCtD
Acetylcysteine—Pruritus—Prednisone—psoriasis	0.000214	0.000613	CcSEcCtD
Acetylcysteine—Nausea—Betamethasone—psoriasis	0.000206	0.000591	CcSEcCtD
Acetylcysteine—Nausea—Dexamethasone—psoriasis	0.000206	0.000591	CcSEcCtD
Acetylcysteine—Urticaria—Methotrexate—psoriasis	0.000201	0.000576	CcSEcCtD
Acetylcysteine—Dizziness—Prednisone—psoriasis	0.0002	0.000573	CcSEcCtD
Acetylcysteine—Body temperature increased—Methotrexate—psoriasis	0.0002	0.000573	CcSEcCtD
Acetylcysteine—Vomiting—Prednisone—psoriasis	0.000192	0.000551	CcSEcCtD
Acetylcysteine—Rash—Prednisone—psoriasis	0.000191	0.000547	CcSEcCtD
Acetylcysteine—Dermatitis—Prednisone—psoriasis	0.000191	0.000546	CcSEcCtD
Acetylcysteine—Hypersensitivity—Methotrexate—psoriasis	0.000186	0.000534	CcSEcCtD
Acetylcysteine—Nausea—Prednisone—psoriasis	0.00018	0.000515	CcSEcCtD
Acetylcysteine—Pruritus—Methotrexate—psoriasis	0.000179	0.000513	CcSEcCtD
Acetylcysteine—Dizziness—Methotrexate—psoriasis	0.000167	0.000479	CcSEcCtD
Acetylcysteine—Vomiting—Methotrexate—psoriasis	0.000161	0.000461	CcSEcCtD
Acetylcysteine—Rash—Methotrexate—psoriasis	0.000159	0.000457	CcSEcCtD
Acetylcysteine—Dermatitis—Methotrexate—psoriasis	0.000159	0.000456	CcSEcCtD
Acetylcysteine—Nausea—Methotrexate—psoriasis	0.00015	0.00043	CcSEcCtD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—NFKB1—psoriasis	0.000135	0.000428	CbGpPWpGaD
Acetylcysteine—CHUK—MyD88 dependent cascade initiated on endosome—IL6—psoriasis	0.000135	0.000427	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—TNF—psoriasis	0.000135	0.000427	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—ICAM1—psoriasis	0.000135	0.000426	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—LEP—psoriasis	0.000135	0.000426	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-Like Receptors Cascades—NFKB1—psoriasis	0.000134	0.000423	CbGpPWpGaD
Acetylcysteine—CHUK—TCR Signaling Pathway—IL6—psoriasis	0.000133	0.00042	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by SCF-KIT—STAT3—psoriasis	0.000133	0.00042	CbGpPWpGaD
Acetylcysteine—IKBKB—BDNF signaling pathway—NFKB1—psoriasis	0.000132	0.000416	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—NFKBIA—psoriasis	0.000131	0.000416	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—LEP—psoriasis	0.000131	0.000415	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HLA-E—psoriasis	0.00013	0.000413	CbGpPWpGaD
Acetylcysteine—CHUK—BDNF signaling pathway—STAT3—psoriasis	0.00013	0.000413	CbGpPWpGaD
Acetylcysteine—CHUK—TNF alpha Signaling Pathway—IL6—psoriasis	0.00013	0.000412	CbGpPWpGaD
Acetylcysteine—CHUK—Toll Like Receptor 9 (TLR9) Cascade—IL6—psoriasis	0.00013	0.000412	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis Modulation and Signaling—TP53—psoriasis	0.00013	0.000412	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CYP2S1—psoriasis	0.00013	0.000412	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HCAR2—psoriasis	0.00013	0.000411	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—psoriasis	0.000129	0.000408	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—CAT—psoriasis	0.000128	0.000407	CbGpPWpGaD
Acetylcysteine—CHUK—MyD88:Mal cascade initiated on plasma membrane—IL6—psoriasis	0.000128	0.000405	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—JUN—psoriasis	0.000128	0.000404	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—DDX58—psoriasis	0.000127	0.000403	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HLA-DRB1—psoriasis	0.000127	0.000402	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—VEGFA—psoriasis	0.000127	0.000401	CbGpPWpGaD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—IL6—psoriasis	0.000126	0.0004	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88 cascade initiated on plasma membrane—IL6—psoriasis	0.000126	0.000398	CbGpPWpGaD
Acetylcysteine—IKBKB—Insulin Signaling—JUN—psoriasis	0.000126	0.000398	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HLA-E—psoriasis	0.000125	0.000396	CbGpPWpGaD
Acetylcysteine—IKBKB—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—psoriasis	0.000125	0.000395	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TAGAP—psoriasis	0.000124	0.000393	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—NFKB1—psoriasis	0.000123	0.000389	CbGpPWpGaD
Acetylcysteine—CHUK—MyD88-independent cascade—IL6—psoriasis	0.000123	0.000389	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88 dependent cascade initiated on endosome—IL6—psoriasis	0.000122	0.000388	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—ICAM1—psoriasis	0.000122	0.000386	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—JUN—psoriasis	0.000121	0.000382	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR Signaling Pathway—IL6—psoriasis	0.00012	0.000381	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	0.00012	0.000381	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—IL6—psoriasis	0.00012	0.00038	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—STAT3—psoriasis	0.000119	0.000377	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—NFKBIA—psoriasis	0.000119	0.000377	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HLA-E—psoriasis	0.000118	0.000374	CbGpPWpGaD
Acetylcysteine—IKBKB—BDNF signaling pathway—STAT3—psoriasis	0.000118	0.000374	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF alpha Signaling Pathway—IL6—psoriasis	0.000118	0.000374	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll Like Receptor 9 (TLR9) Cascade—IL6—psoriasis	0.000118	0.000374	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—PPARG—psoriasis	0.000117	0.000371	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—psoriasis	0.000117	0.00037	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—NFKB1—psoriasis	0.000116	0.000368	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88:Mal cascade initiated on plasma membrane—IL6—psoriasis	0.000116	0.000368	CbGpPWpGaD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—TNF—psoriasis	0.000116	0.000367	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—JUN—psoriasis	0.000116	0.000367	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	0.000116	0.000366	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by Interleukins—IL6—psoriasis	0.000115	0.000363	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—PPARG—psoriasis	0.000114	0.000362	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—NFKB1—psoriasis	0.000114	0.00036	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HLA-E—psoriasis	0.000114	0.000359	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TAGAP—psoriasis	0.000113	0.000357	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—NFKB1—psoriasis	0.000112	0.000353	CbGpPWpGaD
Acetylcysteine—IKBKB—MyD88-independent cascade—IL6—psoriasis	0.000111	0.000353	CbGpPWpGaD
Acetylcysteine—CHUK—Activated TLR4 signalling—IL6—psoriasis	0.000111	0.00035	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—STAT3—psoriasis	0.000111	0.00035	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—TYK2—psoriasis	0.000109	0.000346	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—SOCS1—psoriasis	0.000109	0.000345	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—IL6—psoriasis	0.000109	0.000344	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—STAT3—psoriasis	0.000108	0.000342	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—TYK2—psoriasis	0.000108	0.00034	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—ITGAL—psoriasis	0.000106	0.000336	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—psoriasis	0.000105	0.000333	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	0.000105	0.000332	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—SOCS1—psoriasis	0.000105	0.000331	CbGpPWpGaD
Acetylcysteine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—psoriasis	0.000104	0.000329	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by Interleukins—IL6—psoriasis	0.000104	0.000329	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—VEGFA—psoriasis	0.000103	0.000327	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—NFKB1—psoriasis	0.000103	0.000327	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—TYK2—psoriasis	0.000103	0.000325	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IFNG—psoriasis	0.000102	0.000324	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—VEGFA—psoriasis	0.000102	0.000322	CbGpPWpGaD
Acetylcysteine—IKBKB—Activated TLR4 signalling—IL6—psoriasis	0.0001	0.000317	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—TYK2—psoriasis	0.0001	0.000317	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—APOE—psoriasis	9.98e-05	0.000316	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—REL—psoriasis	9.94e-05	0.000315	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—VEGFA—psoriasis	9.92e-05	0.000314	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—TYK2—psoriasis	9.92e-05	0.000314	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—SOCS1—psoriasis	9.87e-05	0.000313	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—STAT3—psoriasis	9.79e-05	0.00031	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—TYK2—psoriasis	9.75e-05	0.000309	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IFIH1—psoriasis	9.65e-05	0.000306	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ITGAL—psoriasis	9.64e-05	0.000305	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—TP53—psoriasis	9.58e-05	0.000303	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—SOCS1—psoriasis	9.48e-05	0.0003	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—psoriasis	9.43e-05	0.000298	CbGpPWpGaD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—IL6—psoriasis	9.37e-05	0.000296	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HLA-B—psoriasis	9.29e-05	0.000294	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IFNG—psoriasis	9.29e-05	0.000294	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CD8A—psoriasis	9.27e-05	0.000294	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-Like Receptors Cascades—IL6—psoriasis	9.26e-05	0.000293	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by SCF-KIT—IL6—psoriasis	9.26e-05	0.000293	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HLA-C—psoriasis	9.15e-05	0.00029	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TNF—psoriasis	9.05e-05	0.000286	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—TNFAIP3—psoriasis	9.04e-05	0.000286	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—REL—psoriasis	9.02e-05	0.000285	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	9e-05	0.000285	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HLA-B—psoriasis	8.92e-05	0.000282	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—IL6—psoriasis	8.86e-05	0.00028	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IFIH1—psoriasis	8.75e-05	0.000277	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—IL6—psoriasis	8.72e-05	0.000276	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PPARG—psoriasis	8.69e-05	0.000275	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—NFKB1—psoriasis	8.52e-05	0.00027	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—psoriasis	8.49e-05	0.000269	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HLA-B—psoriasis	8.42e-05	0.000267	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CD8A—psoriasis	8.41e-05	0.000266	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-Like Receptors Cascades—IL6—psoriasis	8.4e-05	0.000266	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—NFKB1—psoriasis	8.38e-05	0.000265	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—IL6—psoriasis	8.33e-05	0.000264	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HLA-C—psoriasis	8.3e-05	0.000263	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—IL6—psoriasis	8.29e-05	0.000262	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HLA-A—psoriasis	8.27e-05	0.000262	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—IL6—psoriasis	8.25e-05	0.000261	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CRP—psoriasis	8.21e-05	0.00026	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—IL6—psoriasis	8.21e-05	0.00026	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—TNFAIP3—psoriasis	8.2e-05	0.000259	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HLA-B—psoriasis	8.09e-05	0.000256	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—NFKB1—psoriasis	8e-05	0.000253	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TP53—psoriasis	7.98e-05	0.000252	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	7.94e-05	0.000251	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—TP53—psoriasis	7.81e-05	0.000247	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—NFKB1—psoriasis	7.8e-05	0.000247	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—NFKB1—psoriasis	7.73e-05	0.000245	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	7.72e-05	0.000244	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—IL6—psoriasis	7.72e-05	0.000244	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—IL6—psoriasis	7.72e-05	0.000244	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—STAT3—psoriasis	7.66e-05	0.000242	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—IL6—psoriasis	7.65e-05	0.000242	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—NFKB1—psoriasis	7.6e-05	0.00024	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HLA-E—psoriasis	7.59e-05	0.00024	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—IL6—psoriasis	7.58e-05	0.00024	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HLA-DRB1—psoriasis	7.55e-05	0.000239	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—IL6—psoriasis	7.55e-05	0.000239	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—STAT3—psoriasis	7.53e-05	0.000238	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HLA-A—psoriasis	7.5e-05	0.000237	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—NFKBIA—psoriasis	7.49e-05	0.000237	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCL20—psoriasis	7.45e-05	0.000236	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CRP—psoriasis	7.45e-05	0.000236	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—VEGFA—psoriasis	7.26e-05	0.00023	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—ICAM1—psoriasis	7.25e-05	0.000229	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—NFKBIA—psoriasis	7.19e-05	0.000228	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—STAT3—psoriasis	7.19e-05	0.000228	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—VEGFA—psoriasis	7.08e-05	0.000224	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—IL6—psoriasis	7.04e-05	0.000223	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—STAT3—psoriasis	7.01e-05	0.000222	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	7e-05	0.000222	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—STAT3—psoriasis	6.95e-05	0.00022	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HLA-E—psoriasis	6.89e-05	0.000218	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—IL6—psoriasis	6.86e-05	0.000217	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HLA-DRB1—psoriasis	6.85e-05	0.000217	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	6.84e-05	0.000216	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—STAT3—psoriasis	6.83e-05	0.000216	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.82e-05	0.000216	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—NFKBIA—psoriasis	6.79e-05	0.000215	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCL20—psoriasis	6.75e-05	0.000214	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—ICAM1—psoriasis	6.57e-05	0.000208	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—NFKBIA—psoriasis	6.52e-05	0.000206	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CARM1—psoriasis	6.35e-05	0.000201	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—SOCS1—psoriasis	6.34e-05	0.000201	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—TNF—psoriasis	6.22e-05	0.000197	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—TYK2—psoriasis	6.13e-05	0.000194	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—TNF—psoriasis	6.07e-05	0.000192	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.94e-05	0.000188	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—SOCS1—psoriasis	5.75e-05	0.000182	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD8A—psoriasis	5.63e-05	0.000178	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—TYK2—psoriasis	5.56e-05	0.000176	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CD4—psoriasis	5.55e-05	0.000176	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HLA-B—psoriasis	5.41e-05	0.000171	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL6—psoriasis	5.35e-05	0.000169	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CD4—psoriasis	5.33e-05	0.000169	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—IL6—psoriasis	5.26e-05	0.000166	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD8A—psoriasis	5.1e-05	0.000161	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CD4—psoriasis	5.03e-05	0.000159	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—IL6—psoriasis	5.02e-05	0.000159	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HLA-A—psoriasis	5.01e-05	0.000159	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—JUN—psoriasis	4.97e-05	0.000157	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HLA-B—psoriasis	4.91e-05	0.000155	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—IL6—psoriasis	4.9e-05	0.000155	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL6—psoriasis	4.85e-05	0.000154	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CD4—psoriasis	4.83e-05	0.000153	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CRP—psoriasis	4.78e-05	0.000151	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—NFKB1—psoriasis	4.78e-05	0.000151	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—IL6—psoriasis	4.77e-05	0.000151	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HLA-A—psoriasis	4.63e-05	0.000147	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—NFKB1—psoriasis	4.59e-05	0.000145	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HLA-DRB1—psoriasis	4.58e-05	0.000145	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HLA-A—psoriasis	4.55e-05	0.000144	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—JUN—psoriasis	4.5e-05	0.000142	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—ICAM1—psoriasis	4.4e-05	0.000139	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—NFKBIA—psoriasis	4.36e-05	0.000138	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CRP—psoriasis	4.34e-05	0.000137	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—NFKB1—psoriasis	4.33e-05	0.000137	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—APOE—psoriasis	4.32e-05	0.000137	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—NFKB1—psoriasis	4.16e-05	0.000132	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HLA-DRB1—psoriasis	4.15e-05	0.000131	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SOCS1—psoriasis	4.1e-05	0.00013	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NOS2—psoriasis	4.03e-05	0.000127	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ICAM1—psoriasis	3.99e-05	0.000126	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—NFKBIA—psoriasis	3.96e-05	0.000125	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CAT—psoriasis	3.91e-05	0.000124	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SOCS1—psoriasis	3.72e-05	0.000118	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—TYK2—psoriasis	3.57e-05	0.000113	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IFNG—psoriasis	3.35e-05	0.000106	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TYK2—psoriasis	3.3e-05	0.000104	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—TYK2—psoriasis	3.24e-05	0.000103	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD4—psoriasis	3.23e-05	0.000102	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—APOE—psoriasis	3.04e-05	9.61e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IFNG—psoriasis	3.03e-05	9.6e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—LEP—psoriasis	3.03e-05	9.58e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—APOE—psoriasis	3.03e-05	9.58e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—IL6—psoriasis	3e-05	9.49e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CD4—psoriasis	2.98e-05	9.44e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD4—psoriasis	2.93e-05	9.27e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—JUN—psoriasis	2.89e-05	9.15e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NFKBIA—psoriasis	2.82e-05	8.93e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—NFKB1—psoriasis	2.78e-05	8.81e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—LEP—psoriasis	2.74e-05	8.69e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—APOE—psoriasis	2.74e-05	8.69e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—IL6—psoriasis	2.72e-05	8.61e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PPARG—psoriasis	2.64e-05	8.37e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—JUN—psoriasis	2.62e-05	8.3e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NFKBIA—psoriasis	2.56e-05	8.09e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—NFKB1—psoriasis	2.52e-05	7.99e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—STAT3—psoriasis	2.5e-05	7.92e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TYK2—psoriasis	2.31e-05	7.31e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—STAT3—psoriasis	2.31e-05	7.31e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—STAT3—psoriasis	2.27e-05	7.18e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TYK2—psoriasis	2.09e-05	6.63e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CXCL8—psoriasis	2.01e-05	6.37e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—JUN—psoriasis	1.87e-05	5.92e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CXCL8—psoriasis	1.82e-05	5.77e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NFKB1—psoriasis	1.8e-05	5.7e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL6—psoriasis	1.75e-05	5.53e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—JUN—psoriasis	1.7e-05	5.37e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VEGFA—psoriasis	1.63e-05	5.17e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NFKB1—psoriasis	1.63e-05	5.16e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—STAT3—psoriasis	1.62e-05	5.12e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IL6—psoriasis	1.61e-05	5.11e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL6—psoriasis	1.58e-05	5.01e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VEGFA—psoriasis	1.48e-05	4.69e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—STAT3—psoriasis	1.47e-05	4.64e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TP53—psoriasis	1.23e-05	3.91e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL6—psoriasis	1.13e-05	3.58e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TP53—psoriasis	1.12e-05	3.54e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL6—psoriasis	1.02e-05	3.24e-05	CbGpPWpGaD
